The price of Boston Scientific Corp. (NYSE:BSX) shares last traded on Wall Street rose 1.04% to $87.10.
BSX stock price is now 7.44% away from the 50-day moving average and 20.01% away from the 200-day moving average. The market capitalization of the company currently stands at $128.27B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $90, Goldman recently initiated with Buy rating for Boston Scientific Corp. (NYSE: BSX). On February 01, 2024, Mizuho Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock increasing its target price from $65 to quote $80, while ‘Robert W. Baird’ rates the stock as ‘Outperform’
In other news, Mahoney Michael F, Chairman, President & CEO sold 162,777 shares of the company’s stock on Oct 07 ’24. The stock was sold for $13,775,792 at an average price of $84.63. Upon completion of the transaction, the Chairman, President & CEO now directly owns 1,572,096 shares in the company, valued at $136.93 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 07 ’24, EVP & Group Pres, Cardiology Fitzgerald Joseph Michael sold 132,527 shares of the business’s stock. A total of $11,264,888 was realized by selling the stock at an average price of $85.00. This leaves the insider owning 160,467 shares of the company worth $13.98 million. A total of 0.43% of the company’s stock is owned by insiders.
During the past 12 months, Boston Scientific Corp. has had a low of $48.35 and a high of $86.99. As of last week, the company has a debt-to-equity ratio of 0.54, a current ratio of 1.61, and a quick ratio of 1.14. According to the stock market information, the enterprise value for the company is $136526733312, which is based on a 70.47 price-to-earnings ratio, a 5.42 price-to-earnings-growth ratio, and a beta of 0.80. The fifty day moving average price for BSX is $81.0684 and a two-hundred day moving average price translates $72.5796 for the stock.
The latest earnings results from Boston Scientific Corp. (NYSE: BSX) was released for 2024-06-30. The net profit margin was 12.00% and return on equity was 9.46% for BSX. The company reported revenue of $4.12 billion for the quarter, compared to $3.6 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 14.48 percent.
